Q2 2026 adjusted EBIT rose 17% to $2.5B, with margin up to 5.2% despite lower revenue. Full-year adjusted EBIT and FCF guidance were raised, while special items drove a net loss. Strong cash and liquidity positions support ongoing investment and operational execution.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.